XT
TENX icon

XTX Topco’s Tenax Therapeutics TENX Stock Holding History

XTX Topco’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66M Buy
113,767
+65,916
+138% +$842K 0.02% 1307
2026
Q1 		$765K Buy
+47,851
New +$647K 0.01% 1652
2024
Q1 		– Sell
-532
Closed -$11.7K – 2310
2023
Q4 		$11.7K Buy
+532
New +$12.8K ﹤0.01% 1415

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

XTX Topco's TENX Position: Q2 2026 in Review

XTX Topco increased its Tenax Therapeutics (TENX) stake by 138% in Q2 2026, buying an estimated $842K and bringing the position to 113,767 shares worth $1.66M. The position accounts for 0.02% of the portfolio, ranked #1307.

XTX Topco first reported a position in TENX in Q4 2023 and has held it in 3 quarters since. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • XTX Topco held 113,767 shares of Tenax Therapeutics worth $1.66M as of Q2 2026.
  • XTX Topco bought 65,916 Tenax Therapeutics shares in Q2 2026, an estimated $842K.
  • Tenax Therapeutics made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1307 holding.
  • XTX Topco first reported a position in Tenax Therapeutics in Q4 2023 and has held it in 3 quarters since.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.